GSK plc Adjustments For Finance Income Cost
GSK plc (GLAXF) reported Adjustments For Finance Income Cost of -GBP 532.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceIncomeCost · last filed 2026-03-06
| Period end | Adjustments For Finance Income Cost 12 month | Adjustments For Finance Income Cost 12 month as first filed |
|---|---|---|
| 2025-12-31 | -532.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | -547.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | -677.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | -803.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | -755.00M GBP 20-F · filed 2024-03-05 | -756.00M GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | -842.00M GBP 20-F · filed 2023-03-10 | -848.00M GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | -814.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | -717.00M GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | -669.00M GBP 20-F · filed 2020-03-06 | 669.00M GBP 20-F/A · filed 2018-03-20 |
| 2016-12-31 | -664.00M GBP 20-F · filed 2019-03-15 | 664.00M GBP 20-F/A · filed 2018-03-20 |
| 2015-12-31 | 653.00M GBP 20-F/A · filed 2018-03-20 |